PRMT1 and anemia: Further supporting our results, others have demonstrated that inhibition of PRMT1 through RNAi depleted levels of the activating histone mark H4R3me and increased levels of the repressive H3K9me and H3K27me marks at the β-globin locus in erythrocytes27, contributing to an anemia phenotype.